Black Americans Have 2x the Alzheimer’s Risk—But They’re Underrepresented in Drug Trials
Experts estimate that, by 2023, nearly 40 percent of the more than eight million Americans living with Alzheimer’s and related dementias will be Latino…
Experts estimate that, by 2023, nearly 40 percent of the more than eight million Americans living with Alzheimer’s and related dementias will be Latino…
By 2030, experts estimate that more than 8 million Americans will be living with Alzheimer’s or other forms of dementia. Black Americans will make…
Biogen renounced ownership of their controversial anti-Alzheimer’s drug Aduhelm after years of dismal sales. The company is also halting an ongoing clinical trial set…
About 14 of every 100 of Black Americans older than 65 have Alzheimer’s disease, compared 10 in 100 white Americans of the same age…
Blacks are at higher risk for several health conditions in the U.S. This is true for heart disease, hypertension, type 2 diabetes and stroke,…
As Alzheimer’s and other forms of dementia progress, brain cells and their connections degenerate and die, including those crucial for recalling old memories. That…
The process of finding new treatments for Alzheimer’s disease is one of trial and error — and every “failed” trial generates invaluable new data…
As we journey through life, the risk of developing chronic diseases, including cancer, heart disease and neurological disorders, increases significantly. However, while we all…
Although Being Patient is based in the U.S., our reporting — and the people contributing to the platform — know no borders! This week,…
Around 36 percent of people in England with dementia are unaware they have the condition, according to a new report from the Dementia Commission….
Even after decades of studying Alzheimer’s, Parkinson’s, and other similar conditions, scientists still don’t know what exactly causes the disease to develop. What they…
When the cold and dark winter is setting in, some of us envy animals that can hibernate. This long, deep rest is an example…
On July 6, 2023, the U.S. Food and Drug Administration fully approved the Alzheimer’s drug Leqembi (generic name lecanemab), a monoclonal antibody drug for…
While many people use Alzheimer’s and dementia interchangeably, these don’t mean the same thing. What exactly is the difference? Dementia is a word used…
Familiar scents and odors spark powerful memories for just about anyone. Getting a whiff of freshly baked goods may bring someone back to their…